Risk of serious adverse events associated with biologic and nonbiologic psoriasis systemic therapy: patients ineligible vs eligible for randomized controlled trials. [electronic resource]
Producer: 20120604Description: 463-70 p. digitalISSN:- 1538-3652
- Adult
- Age Factors
- Aged
- Anti-Inflammatory Agents -- adverse effects
- Antibodies, Monoclonal -- adverse effects
- Biological Products -- adverse effects
- Female
- Humans
- Immunosuppressive Agents -- adverse effects
- Keratolytic Agents -- adverse effects
- Male
- Middle Aged
- PUVA Therapy -- adverse effects
- Patient Selection
- Proportional Hazards Models
- Psoriasis -- classification
- Randomized Controlled Trials as Topic
- Risk Assessment
- Spain
No physical items for this record
Publication Type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.